SMTI Sanara MedTech | $33.68 +6.6% | 12/23/2024 | Initiated by | HC Wainwright | - | Buy | $50.00 | N/A | View details for HC Wainwright rating of Sanara MedTech (NASDAQ:SMTI) on 12/23/2024 |
ENGN enGene | $5.83 -2.2% | 12/23/2024 | Initiated by | HC Wainwright | - | Buy | $25.00 | N/A | View details for HC Wainwright rating of enGene (NASDAQ:ENGN) on 12/23/2024 |
ACRS Aclaris Therapeutics | $2.72 -1.8% | 12/23/2024 | Upgraded by | HC Wainwright | - | Neutral -> Buy | $20.00 | N/A | View details for HC Wainwright rating of Aclaris Therapeutics (NASDAQ:ACRS) on 12/23/2024 |
PYXS Pyxis Oncology | $1.69 +9.7% | 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $5.00 | N/A | View details for HC Wainwright rating of Pyxis Oncology (NASDAQ:PYXS) on 12/20/2024 |
IFRX InflaRx | $2.24 +5.2% | 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 -> $8.00 | N/A | View details for HC Wainwright rating of InflaRx (NASDAQ:IFRX) on 12/20/2024 |
ARWR Arrowhead Pharmaceuticals | $19.45 -0.3% | 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $80.00 -> $80.00 | N/A | View details for HC Wainwright rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 12/20/2024 |
|
CYTK Cytokinetics | $48.87 +4.6% | 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $120.00 -> $120.00 | N/A | View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 12/20/2024 |
LGO Largo | $1.70 +1.8% | 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.20 -> $4.20 | N/A | View details for HC Wainwright rating of Largo (NYSE:LGO) on 12/20/2024 |
HUMA Humacyte | $4.64 +34.1% | 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $15.00 | N/A | View details for HC Wainwright rating of Humacyte (NASDAQ:HUMA) on 12/20/2024 |
PSNL Personalis | $5.75 +9.3% | 12/20/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $9.00 -> $11.00 | N/A | View details for HC Wainwright rating of Personalis (NASDAQ:PSNL) on 12/20/2024 |
VRTX Vertex Pharmaceuticals | $397.27 +0.2% | 12/20/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $600.00 -> $535.00 | N/A | View details for HC Wainwright rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 12/20/2024 |
PRTA Prothena | $15.22 -4.9% | 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $84.00 -> $48.00 | N/A | View details for HC Wainwright rating of Prothena (NASDAQ:PRTA) on 12/20/2024 |
VERU Veru | $0.65 +3.3% | 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 -> $3.00 | N/A | View details for HC Wainwright rating of Veru (NASDAQ:VERU) on 12/20/2024 |
LVTX LAVA Therapeutics | $1.03 +4.2% | 12/20/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $6.00 -> $2.00 | N/A | View details for HC Wainwright rating of LAVA Therapeutics (NASDAQ:LVTX) on 12/20/2024 |
ORKA Oruka Therapeutics | $20.31 -2.2% | 12/20/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $45.00 -> $45.00 | N/A | View details for HC Wainwright rating of Oruka Therapeutics (NASDAQ:ORKA) on 12/20/2024 |
ALMS Alumis | $8.82 +2.2% | 12/20/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $26.00 -> $26.00 | N/A | View details for HC Wainwright rating of Alumis (NASDAQ:ALMS) on 12/20/2024 |
AQST Aquestive Therapeutics | $3.65 +0.3% | 12/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Aquestive Therapeutics (NASDAQ:AQST) on 12/20/2024 |
FNV Franco-Nevada | $116.21 +0.9% | 12/20/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $200.00 -> $155.00 | N/A | View details for HC Wainwright rating of Franco-Nevada (NYSE:FNV) on 12/20/2024 |
RNA Avidity Biosciences | $31.82 +2.5% | 12/20/2024 | Initiated by | HC Wainwright | Analyst A. Ghosh | Buy | $72.00 | N/A | View details for HC Wainwright rating of Avidity Biosciences (NASDAQ:RNA) on 12/20/2024 |
AIRJ Montana Technologies | $9.50 +0.7% | 12/20/2024 | Initiated by | HC Wainwright | Analyst A. Dayal | Buy | $12.00 | N/A | View details for HC Wainwright rating of Montana Technologies (NASDAQ:AIRJ) on 12/20/2024 |
CLDX Celldex Therapeutics | $25.14 -0.9% | 12/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $80.00 -> $80.00 | N/A | View details for HC Wainwright rating of Celldex Therapeutics (NASDAQ:CLDX) on 12/19/2024 |
IMNN Imunon | $0.83 -2.8% | 12/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of Imunon (NASDAQ:IMNN) on 12/19/2024 |
GPCR Structure Therapeutics | $27.90 -6.9% | 12/19/2024 | Reiterated by | HC Wainwright | Analyst A. Ghosh | Buy -> Buy | $80.00 -> $80.00 | N/A | View details for HC Wainwright rating of Structure Therapeutics (NASDAQ:GPCR) on 12/19/2024 |
PTN Palatin Technologies | $0.97 +12.5% | 12/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.00 -> $17.00 | N/A | View details for HC Wainwright rating of Palatin Technologies (NYSEAMERICAN:PTN) on 12/19/2024 |
ACET Adicet Bio | $0.91 +5.8% | 12/19/2024 | Reiterated by | HC Wainwright | Analyst E. White | Neutral -> Neutral | | N/A | View details for HC Wainwright rating of Adicet Bio (NASDAQ:ACET) on 12/19/2024 |
SGMO Sangamo Therapeutics | $2.47 +6.9% | 12/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Sangamo Therapeutics (NASDAQ:SGMO) on 12/19/2024 |
ARMP Armata Pharmaceuticals | $1.95 -1.5% | 12/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Armata Pharmaceuticals (NYSEAMERICAN:ARMP) on 12/19/2024 |
UROY Uranium Royalty | $2.13 +0.9% | 12/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.70 -> $7.70 | N/A | View details for HC Wainwright rating of Uranium Royalty (NASDAQ:UROY) on 12/19/2024 |
VSTM Verastem | $4.19 -5.6% | 12/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Verastem (NASDAQ:VSTM) on 12/19/2024 |
SRPT Sarepta Therapeutics | $118.97 -0.4% | 12/19/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Sell -> Sell | $75.00 -> $75.00 | N/A | View details for HC Wainwright rating of Sarepta Therapeutics (NASDAQ:SRPT) on 12/19/2024 |
CGTX Cognition Therapeutics | $0.63 -0.6% | 12/19/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $5.00 -> $6.00 | N/A | View details for HC Wainwright rating of Cognition Therapeutics (NASDAQ:CGTX) on 12/19/2024 |
WRN Western Copper & Gold | $1.04 +3.0% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.25 -> $4.25 | N/A | View details for HC Wainwright rating of Western Copper & Gold (NYSE:WRN) on 12/18/2024 |
VKTX Viking Therapeutics | $42.25 +1.8% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $102.00 -> $102.00 | N/A | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 12/18/2024 |
TNYA Tenaya Therapeutics | $1.67 +18.4% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 -> $18.00 | N/A | View details for HC Wainwright rating of Tenaya Therapeutics (NASDAQ:TNYA) on 12/18/2024 |
JOBY Joby Aviation | $7.69 +6.4% | 12/18/2024 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for HC Wainwright rating of Joby Aviation (NYSE:JOBY) on 12/18/2024 |
RICK RCI Hospitality | $56.80 -0.2% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $98.00 -> $98.00 | N/A | View details for HC Wainwright rating of RCI Hospitality (NASDAQ:RICK) on 12/18/2024 |
EXK Endeavour Silver | $3.71 +1.6% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.25 -> $7.25 | N/A | View details for HC Wainwright rating of Endeavour Silver (NYSE:EXK) on 12/18/2024 |
HALO Halozyme Therapeutics | $46.96 -0.8% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $68.00 -> $68.00 | N/A | View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 12/18/2024 |
ECOR electroCore | $15.27 +5.2% | 12/18/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $22.00 -> $25.00 | N/A | View details for HC Wainwright rating of electroCore (NASDAQ:ECOR) on 12/18/2024 |
ALXO ALX Oncology | $1.62 +9.5% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $25.00 -> $25.00 | N/A | View details for HC Wainwright rating of ALX Oncology (NASDAQ:ALXO) on 12/18/2024 |
If you see ONE chart today… make it this one (Ad) $1 Trillion…
That’s how much Big Tech is set to spend on AI investment in the coming months—according to Goldman Sachs.
This investment is driving an A.I. boom that’s being felt across many industries…
Including a specific group of energy tickers since A.I. data centers use a massive amount of power.
One of those tickers is CEG, up nearly 600% in the last 3 years…
Combined with the upcoming presidential election, we have the recipe for a major shakeup in the market.
You see, each time the U.S. elects a new president, one overlooked part of the energy sector tends to see a big move.
Fact is… this energy niche is BOOMING. And expects this underappreciated niche to continue rallying well into 2026. |
PDSB PDS Biotechnology | $1.65 -5.7% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $21.00 -> $21.00 | N/A | View details for HC Wainwright rating of PDS Biotechnology (NASDAQ:PDSB) on 12/18/2024 |
KRYS Krystal Biotech | $164.83 +2.5% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $221.00 -> $221.00 | N/A | View details for HC Wainwright rating of Krystal Biotech (NASDAQ:KRYS) on 12/18/2024 |
CADL Candel Therapeutics | $8.75 -12.1% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $19.00 | N/A | View details for HC Wainwright rating of Candel Therapeutics (NASDAQ:CADL) on 12/18/2024 |
CRDL Cardiol Therapeutics | $1.28 -2.3% | 12/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for HC Wainwright rating of Cardiol Therapeutics (NASDAQ:CRDL) on 12/18/2024 |
FGEN FibroGen | $0.40 +13.1% | 12/17/2024 | Upgraded by | HC Wainwright | Analyst M. Keller | Strong-Buy | | N/A | View details for HC Wainwright rating of FibroGen (NASDAQ:FGEN) on 12/17/2024 |
HRMY Harmony Biosciences | $34.28 +1.2% | 12/17/2024 | Initiated by | HC Wainwright | Analyst P. Trucchio | Buy | $75.00 | N/A | View details for HC Wainwright rating of Harmony Biosciences (NASDAQ:HRMY) on 12/17/2024 |
MITK Mitek Systems | $11.43 +3.0% | 12/17/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $11.00 -> $13.00 | N/A | View details for HC Wainwright rating of Mitek Systems (NASDAQ:MITK) on 12/17/2024 |
NMG Nouveau Monde Graphite | $1.43 -12.3% | 12/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 -> $3.00 | N/A | View details for HC Wainwright rating of Nouveau Monde Graphite (NYSE:NMG) on 12/17/2024 |
ARCT Arcturus Therapeutics | $15.48 +4.3% | 12/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $63.00 -> $63.00 | N/A | View details for HC Wainwright rating of Arcturus Therapeutics (NASDAQ:ARCT) on 12/17/2024 |
DARE Daré Bioscience | $2.71 -9.1% | 12/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of Daré Bioscience (NASDAQ:DARE) on 12/17/2024 |
BHVN Biohaven | $36.26 +2.6% | 12/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $59.00 -> $59.00 | N/A | View details for HC Wainwright rating of Biohaven (NYSE:BHVN) on 12/17/2024 |
FENC Fennec Pharmaceuticals | $5.99 +2.6% | 12/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $13.00 -> $13.00 | N/A | View details for HC Wainwright rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 12/17/2024 |
ANNX Annexon | $5.23 +0.2% | 12/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for HC Wainwright rating of Annexon (NASDAQ:ANNX) on 12/17/2024 |
FHTX Foghorn Therapeutics | $5.14 +3.2% | 12/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 -> $13.00 | N/A | View details for HC Wainwright rating of Foghorn Therapeutics (NASDAQ:FHTX) on 12/17/2024 |
PHAR Pharming Group | $9.10 +1.8% | 12/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $37.00 -> $37.00 | N/A | View details for HC Wainwright rating of Pharming Group (NASDAQ:PHAR) on 12/17/2024 |
APRE Aprea Therapeutics | $3.05 -5.6% | 12/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 -> $20.00 | N/A | View details for HC Wainwright rating of Aprea Therapeutics (NASDAQ:APRE) on 12/17/2024 |
CRVO CervoMed | $2.23
| 12/17/2024 | Downgraded by | HC Wainwright | Analyst R. Selvaraju | Buy -> Neutral | | N/A | View details for HC Wainwright rating of CervoMed (NASDAQ:CRVO) on 12/17/2024 |
LRMR Larimar Therapeutics | $4.01 +0.8% | 12/16/2024 | Reiterated by | HC Wainwright | Analyst E. White | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for HC Wainwright rating of Larimar Therapeutics (NASDAQ:LRMR) on 12/16/2024 |
VRDN Viridian Therapeutics | $19.03 +1.6% | 12/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $34.00 -> $34.00 | N/A | View details for HC Wainwright rating of Viridian Therapeutics (NASDAQ:VRDN) on 12/16/2024 |
ACHR Archer Aviation | $9.49 +12.7% | 12/16/2024 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $12.50 -> $12.50 | N/A | View details for HC Wainwright rating of Archer Aviation (NYSE:ACHR) on 12/16/2024 |
BCYC Bicycle Therapeutics | $14.68 -2.1% | 12/16/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $55.00 -> $33.00 | N/A | View details for HC Wainwright rating of Bicycle Therapeutics (NASDAQ:BCYC) on 12/16/2024 |
ASRT Assertio | $0.89 +5.1% | 12/16/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $4.00 -> $4.00 | N/A | View details for HC Wainwright rating of Assertio (NASDAQ:ASRT) on 12/16/2024 |
SPRB Spruce Biosciences | $0.40 +4.7% | 12/16/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | | N/A | View details for HC Wainwright rating of Spruce Biosciences (NASDAQ:SPRB) on 12/16/2024 |
NMRA Neumora Therapeutics | $10.85 +3.3% | 12/16/2024 | Reiterated by | HC Wainwright | Analyst D. Tsao | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for HC Wainwright rating of Neumora Therapeutics (NASDAQ:NMRA) on 12/16/2024 |
PYPD PolyPid | $3.22 -8.0% | 12/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $14.00 -> $14.00 | N/A | View details for HC Wainwright rating of PolyPid (NASDAQ:PYPD) on 12/16/2024 |
NBIX Neurocrine Biosciences | $135.42 +0.3% | 12/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $190.00 -> $190.00 | N/A | View details for HC Wainwright rating of Neurocrine Biosciences (NASDAQ:NBIX) on 12/16/2024 |
BBIO BridgeBio Pharma | $26.49 +1.1% | 12/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $49.00 -> $49.00 | N/A | View details for HC Wainwright rating of BridgeBio Pharma (NASDAQ:BBIO) on 12/16/2024 |
CARM Carisma Therapeutics | $0.42 -5.3% | 12/16/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Neutral | | N/A | View details for HC Wainwright rating of Carisma Therapeutics (NASDAQ:CARM) on 12/16/2024 |
CKPT Checkpoint Therapeutics | $3.75 +11.3% | 12/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 -> $20.00 | N/A | View details for HC Wainwright rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 12/16/2024 |
BMEA Biomea Fusion | $4.23 +3.7% | 12/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $40.00 -> $40.00 | N/A | View details for HC Wainwright rating of Biomea Fusion (NASDAQ:BMEA) on 12/16/2024 |
DGHI Digihost Technology | $1.77 -1.7% | 12/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.50 -> $2.50 | N/A | View details for HC Wainwright rating of Digihost Technology (NASDAQ:DGHI) on 12/16/2024 |
BNTC Benitec Biopharma | $11.41 -6.2% | 12/16/2024 | Initiated by | HC Wainwright | Analyst P. Trucchio | Buy | $28.00 | N/A | View details for HC Wainwright rating of Benitec Biopharma (NASDAQ:BNTC) on 12/16/2024 |
DEF Defiance Silver | C$0.18
| 12/12/2024 | Upgraded by | HC Wainwright | Analyst K. Dede | Strong-Buy | | N/A | View details for HC Wainwright rating of Defiance Silver (CVE:DEF) on 12/12/2024 |
DEFTF DeFi Technologies | $2.79 +1.1% | 12/12/2024 | Upgraded by | HC Wainwright | Analyst K. Dede | Strong-Buy | | N/A | View details for HC Wainwright rating of DeFi Technologies (OTC:DEFTF) on 12/12/2024 |
XOMA XOMA | $27.13 +8.0% | 12/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $123.00 -> $123.00 | N/A | View details for HC Wainwright rating of XOMA (NASDAQ:XOMA) on 12/13/2024 |
NYXH Nyxoah | $8.01 +0.1% | 12/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.00 -> $17.00 | N/A | View details for HC Wainwright rating of Nyxoah (NASDAQ:NYXH) on 12/13/2024 |
ABSI Absci | $2.99 +2.4% | 12/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Absci (NASDAQ:ABSI) on 12/13/2024 |
ELVA Electrovaya | $2.18 +3.3% | 12/13/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $16.00 -> $10.00 | N/A | View details for HC Wainwright rating of Electrovaya (NASDAQ:ELVA) on 12/13/2024 |
ITOS iTeos Therapeutics | $7.42 +2.8% | 12/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $21.00 -> $21.00 | N/A | View details for HC Wainwright rating of iTeos Therapeutics (NASDAQ:ITOS) on 12/13/2024 |
ELEV Elevation Oncology | $0.58 -7.3% | 12/13/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 -> $6.00 | N/A | View details for HC Wainwright rating of Elevation Oncology (NASDAQ:ELEV) on 12/13/2024 |
KROS Keros Therapeutics | $17.03 +0.7% | 12/13/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $100.00 -> $47.00 | N/A | View details for HC Wainwright rating of Keros Therapeutics (NASDAQ:KROS) on 12/13/2024 |
TRVI Trevi Therapeutics | $4.05 -2.4% | 12/12/2024 | Target Raised by | HC Wainwright | Analyst O. Livnat | Buy -> Buy | $6.00 -> $7.50 | N/A | View details for HC Wainwright rating of Trevi Therapeutics (NASDAQ:TRVI) on 12/12/2024 |
ESPR Esperion Therapeutics | $2.19 +0.9% | 12/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 -> $16.00 | N/A | View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 12/12/2024 |
ATOS Atossa Therapeutics | $0.96 -1.7% | 12/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Atossa Therapeutics (NASDAQ:ATOS) on 12/12/2024 |
PRAX Praxis Precision Medicines | $76.52 +5.1% | 12/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $120.00 -> $120.00 | N/A | View details for HC Wainwright rating of Praxis Precision Medicines (NASDAQ:PRAX) on 12/12/2024 |
XENE Xenon Pharmaceuticals | $38.63 -0.7% | 12/12/2024 | Reiterated by | HC Wainwright | Analyst D. Tsao | Buy -> Buy | $53.00 -> $53.00 | N/A | View details for HC Wainwright rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 12/12/2024 |
SLDB Solid Biosciences | $4.16 +3.7% | 12/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 -> $16.00 | N/A | View details for HC Wainwright rating of Solid Biosciences (NASDAQ:SLDB) on 12/12/2024 |
IRD Opus Genetics | $0.98 -0.9% | 12/12/2024 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $8.00 -> $8.00 | N/A | View details for HC Wainwright rating of Opus Genetics (NASDAQ:IRD) on 12/12/2024 |
PHAT Phathom Pharmaceuticals | $7.45 -4.7% | 12/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $28.00 -> $28.00 | N/A | View details for HC Wainwright rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 12/12/2024 |
BLCO Bausch + Lomb | $18.00 +0.3% | 12/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $23.00 -> $23.00 | N/A | View details for HC Wainwright rating of Bausch + Lomb (NYSE:BLCO) on 12/12/2024 |
Cackling Kamala hates this company (Ad) Do you want to see one of the most exciting election trades of all time?
A trade that could help America become 100% energy independent…
Reduce energy costs to virtually zero…
And hand investors what could be a stunning return in just a few years’ time?
It all has to do with a little known company that is helping to kick off the next great American energy revolution. Before that happens, you need to see the details here. |
BCTX BriaCell Therapeutics | $0.56 -4.1% | 12/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for HC Wainwright rating of BriaCell Therapeutics (NASDAQ:BCTX) on 12/12/2024 |
PRQR ProQR Therapeutics | $2.63 +1.5% | 12/12/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of ProQR Therapeutics (NASDAQ:PRQR) on 12/12/2024 |
IPA ImmunoPrecise Antibodies | $0.40 -4.8% | 12/11/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $9.00 -> $7.00 | N/A | View details for HC Wainwright rating of ImmunoPrecise Antibodies (NASDAQ:IPA) on 12/11/2024 |
ADCT ADC Therapeutics | $1.96 -7.5% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | | N/A | View details for HC Wainwright rating of ADC Therapeutics (NYSE:ADCT) on 12/11/2024 |
VGZ Vista Gold | $0.57 +5.1% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.75 -> $2.75 | N/A | View details for HC Wainwright rating of Vista Gold (NYSE:VGZ) on 12/11/2024 |
ANAB AnaptysBio | $14.55 -3.0% | 12/11/2024 | Downgraded by | HC Wainwright | Analyst E. Bodnar | Buy -> Neutral | $52.00 -> $19.00 | N/A | View details for HC Wainwright rating of AnaptysBio (NASDAQ:ANAB) on 12/11/2024 |
PHAR Pharming Group | $9.10 +1.8% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $37.00 -> $37.00 | N/A | View details for HC Wainwright rating of Pharming Group (NASDAQ:PHAR) on 12/11/2024 |
RDW Redwire | $13.89 +9.4% | 12/11/2024 | Reiterated by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $18.00 -> $18.00 | N/A | View details for HC Wainwright rating of Redwire (NYSE:RDW) on 12/11/2024 |
SUUN SolarBank | $2.11 -1.4% | 12/11/2024 | Initiated by | HC Wainwright | Analyst A. Dayal | Buy | $6.00 | N/A | View details for HC Wainwright rating of SolarBank (NASDAQ:SUUN) on 12/11/2024 |
UUUU Energy Fuels | $5.30 -2.0% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $11.00 | N/A | View details for HC Wainwright rating of Energy Fuels (NYSE:UUUU) on 12/11/2024 |
SLRN Acelyrin | $3.15 -2.2% | 12/11/2024 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Neutral -> Neutral | $8.00 -> $8.00 | N/A | View details for HC Wainwright rating of Acelyrin (NASDAQ:SLRN) on 12/11/2024 |
IMNN Imunon | $0.83 -2.8% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of Imunon (NASDAQ:IMNN) on 12/11/2024 |
OLMA Olema Pharmaceuticals | $6.10 +5.4% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for HC Wainwright rating of Olema Pharmaceuticals (NASDAQ:OLMA) on 12/11/2024 |
CMRX Chimerix | $2.99 +4.9% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $11.00 | N/A | View details for HC Wainwright rating of Chimerix (NASDAQ:CMRX) on 12/11/2024 |
LGND Ligand Pharmaceuticals | $114.64 +0.6% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | | N/A | View details for HC Wainwright rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 12/11/2024 |
LSTA Lisata Therapeutics | $2.71 +7.5% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for HC Wainwright rating of Lisata Therapeutics (NASDAQ:LSTA) on 12/11/2024 |
COGT Cogent Biosciences | $7.84 +0.5% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | | N/A | View details for HC Wainwright rating of Cogent Biosciences (NASDAQ:COGT) on 12/11/2024 |
YMAB Y-mAbs Therapeutics | $8.28 -3.4% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | | N/A | View details for HC Wainwright rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 12/11/2024 |
NRIX Nurix Therapeutics | $19.83 -1.0% | 12/11/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $30.00 -> $35.00 | N/A | View details for HC Wainwright rating of Nurix Therapeutics (NASDAQ:NRIX) on 12/11/2024 |
TRML Tourmaline Bio | $20.65 +1.5% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $49.00 -> $49.00 | N/A | View details for HC Wainwright rating of Tourmaline Bio (NASDAQ:TRML) on 12/11/2024 |
ARVN Arvinas | $18.48 +3.6% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $87.00 -> $87.00 | N/A | View details for HC Wainwright rating of Arvinas (NASDAQ:ARVN) on 12/11/2024 |
TCRX TScan Therapeutics | $2.97 +1.4% | 12/11/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for HC Wainwright rating of TScan Therapeutics (NASDAQ:TCRX) on 12/11/2024 |
ACXP Acurx Pharmaceuticals | $0.83 +8.8% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of Acurx Pharmaceuticals (NASDAQ:ACXP) on 12/10/2024 |
ANGO AngioDynamics | $8.89 +3.6% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $14.00 -> $14.00 | N/A | View details for HC Wainwright rating of AngioDynamics (NASDAQ:ANGO) on 12/10/2024 |
QURE uniQure | $16.98 +9.8% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $25.00 -> $25.00 | N/A | View details for HC Wainwright rating of uniQure (NASDAQ:QURE) on 12/10/2024 |
VOR Vor Biopharma | $0.87 -2.2% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.50 -> $17.50 | N/A | View details for HC Wainwright rating of Vor Biopharma (NYSE:VOR) on 12/10/2024 |
NVAX Novavax | $8.70 +0.2% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $19.00 -> $19.00 | N/A | View details for HC Wainwright rating of Novavax (NASDAQ:NVAX) on 12/10/2024 |
ATXS Astria Therapeutics | $9.56 +1.2% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 -> $16.00 | N/A | View details for HC Wainwright rating of Astria Therapeutics (NASDAQ:ATXS) on 12/10/2024 |
ATYR Atyr PHARMA | $3.35 +6.3% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $35.00 -> $35.00 | N/A | View details for HC Wainwright rating of Atyr PHARMA (NASDAQ:ATYR) on 12/10/2024 |
CRIS Curis | $3.08 +0.3% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 -> $20.00 | N/A | View details for HC Wainwright rating of Curis (NASDAQ:CRIS) on 12/10/2024 |
SGMO Sangamo Therapeutics | $2.47 +6.9% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Sangamo Therapeutics (NASDAQ:SGMO) on 12/10/2024 |
NKTR Nektar Therapeutics | $0.93 -1.3% | 12/10/2024 | Initiated by | HC Wainwright | Analyst A. He | Buy | $6.50 | N/A | View details for HC Wainwright rating of Nektar Therapeutics (NASDAQ:NKTR) on 12/10/2024 |
UAMY United States Antimony | $1.99 +13.1% | 12/10/2024 | Initiated by | HC Wainwright | Analyst H. Ihle | Buy | $2.50 | N/A | View details for HC Wainwright rating of United States Antimony (NYSE:UAMY) on 12/10/2024 |
XPL Solitario Resources | $0.61 +3.4% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $1.20 -> $1.20 | N/A | View details for HC Wainwright rating of Solitario Resources (NYSEAMERICAN:XPL) on 12/10/2024 |
SNDX Syndax Pharmaceuticals | $13.08 +1.8% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $51.00 -> $51.00 | N/A | View details for HC Wainwright rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 12/10/2024 |
APTO Aptose Biosciences | $0.28 +63.9% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.00 -> $2.00 | N/A | View details for HC Wainwright rating of Aptose Biosciences (NASDAQ:APTO) on 12/10/2024 |
BMEA Biomea Fusion | $4.23 +3.7% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $40.00 -> $40.00 | N/A | View details for HC Wainwright rating of Biomea Fusion (NASDAQ:BMEA) on 12/10/2024 |
RIGL Rigel Pharmaceuticals | $17.09 -0.7% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $57.00 -> $57.00 | N/A | View details for HC Wainwright rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 12/10/2024 |
KRYS Krystal Biotech | $164.83 +2.5% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $221.00 -> $221.00 | N/A | View details for HC Wainwright rating of Krystal Biotech (NASDAQ:KRYS) on 12/10/2024 |
GERN Geron | $3.49 -4.6% | 12/10/2024 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for HC Wainwright rating of Geron (NASDAQ:GERN) on 12/10/2024 |
ACLX Arcellx | $75.54 +0.4% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $115.00 -> $115.00 | N/A | View details for HC Wainwright rating of Arcellx (NASDAQ:ACLX) on 12/10/2024 |
AFMD Affimed | $1.19 +0.8% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Affimed (NASDAQ:AFMD) on 12/10/2024 |
MGX Metagenomi | $4.05 +4.9% | 12/10/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $7.00 -> $14.00 | N/A | View details for HC Wainwright rating of Metagenomi (NASDAQ:MGX) on 12/10/2024 |
LEGN Legend Biotech | $34.08 +0.2% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $73.00 -> $73.00 | N/A | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 12/10/2024 |
PTGX Protagonist Therapeutics | $41.49 +4.9% | 12/10/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 -> $50.00 | N/A | View details for HC Wainwright rating of Protagonist Therapeutics (NASDAQ:PTGX) on 12/10/2024 |
BEAM Beam Therapeutics | $29.01 +8.0% | 12/9/2024 | Reiterated by | HC Wainwright | Analyst P. Trucchio | Buy -> Buy | $80.00 -> $80.00 | N/A | View details for HC Wainwright rating of Beam Therapeutics (NASDAQ:BEAM) on 12/9/2024 |
SLN Silence Therapeutics | $6.88 +8.5% | 12/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $75.00 -> $75.00 | N/A | View details for HC Wainwright rating of Silence Therapeutics (NASDAQ:SLN) on 12/9/2024 |
FUFU BitFuFu | $4.84 -4.7% | 12/9/2024 | Reiterated by | HC Wainwright | Analyst K. Dede | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of BitFuFu (NASDAQ:FUFU) on 12/9/2024 |
UEC Uranium Energy | $7.08 -5.1% | 12/9/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $10.25 -> $11.00 | N/A | View details for HC Wainwright rating of Uranium Energy (NYSEAMERICAN:UEC) on 12/9/2024 |
IPHA Innate Pharma | $2.05 -5.1% | 12/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.50 -> $11.50 | N/A | View details for HC Wainwright rating of Innate Pharma (NASDAQ:IPHA) on 12/9/2024 |
Cackling Kamala hates this company (Ad) Do you want to see one of the most exciting election trades of all time?
A trade that could help America become 100% energy independent…
Reduce energy costs to virtually zero…
And hand investors what could be a stunning return in just a few years’ time?
It all has to do with a little known company that is helping to kick off the next great American energy revolution. Before that happens, you need to see the details here. |
IRON Disc Medicine | $64.50 +2.5% | 12/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $118.00 -> $118.00 | N/A | View details for HC Wainwright rating of Disc Medicine (NASDAQ:IRON) on 12/9/2024 |
CGON CG Oncology | $28.67 +2.3% | 12/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $75.00 -> $75.00 | N/A | View details for HC Wainwright rating of CG Oncology (NASDAQ:CGON) on 12/6/2024 |
ARQQ Arqit Quantum | $30.50 +13.3% | 12/6/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $22.00 -> $27.00 | N/A | View details for HC Wainwright rating of Arqit Quantum (NASDAQ:ARQQ) on 12/6/2024 |
KALV KalVista Pharmaceuticals | $8.36 +3.3% | 12/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 -> $20.00 | N/A | View details for HC Wainwright rating of KalVista Pharmaceuticals (NASDAQ:KALV) on 12/6/2024 |
TARA Protara Therapeutics | $5.39 +4.1% | 12/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $23.00 -> $23.00 | N/A | View details for HC Wainwright rating of Protara Therapeutics (NASDAQ:TARA) on 12/6/2024 |
ZYXI Zynex | $8.25 -1.8% | 12/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.00 -> $17.00 | N/A | View details for HC Wainwright rating of Zynex (NASDAQ:ZYXI) on 12/6/2024 |
BHST BioHarvest Sciences | $6.29 +1.5% | 12/6/2024 | Initiated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $14.00 -> $14.00 | N/A | View details for HC Wainwright rating of BioHarvest Sciences (NASDAQ:BHST) on 12/6/2024 |
BCAX Bicara Therapeutics | $17.59 +6.0% | 12/6/2024 | Initiated by | HC Wainwright | Analyst R. Burns | Buy | $42.00 | N/A | View details for HC Wainwright rating of Bicara Therapeutics (NASDAQ:BCAX) on 12/6/2024 |
AGEN Agenus | $2.83 +2.5% | 12/5/2024 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Neutral -> Neutral | | N/A | View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 12/5/2024 |
BTCM BIT Mining | $2.86 +8.3% | 12/5/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | | N/A | View details for HC Wainwright rating of BIT Mining (NYSE:BTCM) on 12/5/2024 |
GLDG GoldMining | $0.84 +5.0% | 12/5/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $5.25 -> $5.50 | N/A | View details for HC Wainwright rating of GoldMining (NYSEAMERICAN:GLDG) on 12/5/2024 |
CRVO CervoMed | $2.23
| 12/5/2024 | Initiated by | HC Wainwright | Analyst R. Selvaraju | Buy | $42.00 | N/A | View details for HC Wainwright rating of CervoMed (NASDAQ:CRVO) on 12/5/2024 |
EYPT EyePoint Pharmaceuticals | $7.10 -0.3% | 12/5/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $22.00 -> $22.00 | N/A | View details for HC Wainwright rating of EyePoint Pharmaceuticals (NASDAQ:EYPT) on 12/5/2024 |
AMLX Amylyx Pharmaceuticals | $4.05 +2.3% | 12/5/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 12/5/2024 |
TRVI Trevi Therapeutics | $4.05 -2.4% | 12/4/2024 | Reiterated by | HC Wainwright | Analyst O. Livnat | Buy -> Buy | | N/A | View details for HC Wainwright rating of Trevi Therapeutics (NASDAQ:TRVI) on 12/4/2024 |
LCTX Lineage Cell Therapeutics | $0.56 +11.2% | 12/4/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $7.00 -> $9.00 | N/A | View details for HC Wainwright rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 12/4/2024 |
CKPT Checkpoint Therapeutics | $3.75 +11.3% | 12/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 -> $20.00 | N/A | View details for HC Wainwright rating of Checkpoint Therapeutics (NASDAQ:CKPT) on 12/4/2024 |
PCRX Pacira BioSciences | $18.98 -3.0% | 12/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $39.00 -> $39.00 | N/A | View details for HC Wainwright rating of Pacira BioSciences (NASDAQ:PCRX) on 12/4/2024 |
GPCR Structure Therapeutics | $27.90 -6.9% | 12/4/2024 | Initiated by | HC Wainwright | Analyst A. Ghosh | Buy | $80.00 | N/A | View details for HC Wainwright rating of Structure Therapeutics (NASDAQ:GPCR) on 12/4/2024 |
CHRS Coherus BioSciences | $1.52 +2.7% | 12/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Coherus BioSciences (NASDAQ:CHRS) on 12/4/2024 |
RNAC Cartesian Therapeutics | $19.02 -1.3% | 12/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $41.00 -> $45.00 | N/A | View details for HC Wainwright rating of Cartesian Therapeutics (NASDAQ:RNAC) on 12/4/2024 |
OVID Ovid Therapeutics | $1.00 -2.0% | 12/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 -> $3.00 | N/A | View details for HC Wainwright rating of Ovid Therapeutics (NASDAQ:OVID) on 12/4/2024 |
RYTM Rhythm Pharmaceuticals | $56.12 +1.2% | 12/4/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $69.00 -> $69.00 | N/A | View details for HC Wainwright rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 12/4/2024 |
TERN Terns Pharmaceuticals | $5.86 -3.1% | 12/4/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | $7.50 -> $7.50 | N/A | View details for HC Wainwright rating of Terns Pharmaceuticals (NASDAQ:TERN) on 12/4/2024 |
RLAY Relay Therapeutics | $4.16 -2.3% | 12/4/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $20.00 -> $16.00 | N/A | View details for HC Wainwright rating of Relay Therapeutics (NASDAQ:RLAY) on 12/4/2024 |
RVMD Revolution Medicines | $44.06 +1.8% | 12/4/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $64.00 -> $72.00 | N/A | View details for HC Wainwright rating of Revolution Medicines (NASDAQ:RVMD) on 12/4/2024 |
MARA MARA | $19.96 -2.0% | 12/4/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $28.00 -> $28.00 | N/A | View details for HC Wainwright rating of MARA (NASDAQ:MARA) on 12/4/2024 |
APTO Aptose Biosciences | $0.28 +63.9% | 12/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.00 -> $2.00 | N/A | View details for HC Wainwright rating of Aptose Biosciences (NASDAQ:APTO) on 12/3/2024 |
HIVE HIVE Digital Technologies | $3.13 -0.3% | 12/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 -> $8.00 | N/A | View details for HC Wainwright rating of HIVE Digital Technologies (NASDAQ:HIVE) on 12/3/2024 |
ARWR Arrowhead Pharmaceuticals | $19.45 -0.3% | 12/3/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $60.00 -> $80.00 | N/A | View details for HC Wainwright rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 12/3/2024 |
FEMY Femasys | $1.09 -0.9% | 12/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 12/3/2024 |
ATYR Atyr PHARMA | $3.35 +6.3% | 12/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $35.00 -> $35.00 | N/A | View details for HC Wainwright rating of Atyr PHARMA (NASDAQ:ATYR) on 12/3/2024 |
CLSK CleanSpark | $11.14 +2.1% | 12/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $27.00 -> $27.00 | N/A | View details for HC Wainwright rating of CleanSpark (NASDAQ:CLSK) on 12/3/2024 |
TRX TRX Gold | $0.30 -2.7% | 12/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $1.40 -> $1.50 | N/A | View details for HC Wainwright rating of TRX Gold (NYSE:TRX) on 12/3/2024 |
RLYB Rallybio | $0.95 -2.7% | 12/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 -> $5.00 | N/A | View details for HC Wainwright rating of Rallybio (NASDAQ:RLYB) on 12/3/2024 |
OCUL Ocular Therapeutix | $8.50 +0.6% | 12/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for HC Wainwright rating of Ocular Therapeutix (NASDAQ:OCUL) on 12/3/2024 |
SRPT Sarepta Therapeutics | $118.97 -0.4% | 12/3/2024 | Target Lowered by | HC Wainwright | Analyst M. Kapoor | Sell -> Sell | $80.00 -> $75.00 | N/A | View details for HC Wainwright rating of Sarepta Therapeutics (NASDAQ:SRPT) on 12/3/2024 |
ESPR Esperion Therapeutics | $2.19 +0.9% | 12/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 -> $16.00 | N/A | View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 12/3/2024 |
BCTX BriaCell Therapeutics | $0.56 -4.1% | 12/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for HC Wainwright rating of BriaCell Therapeutics (NASDAQ:BCTX) on 12/3/2024 |
JANX Janux Therapeutics | $56.83 +0.1% | 12/3/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $63.00 -> $70.00 | N/A | View details for HC Wainwright rating of Janux Therapeutics (NASDAQ:JANX) on 12/3/2024 |
NVCR NovoCure | $30.80 +1.3% | 12/2/2024 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Buy -> Buy | $30.00 -> $38.00 | N/A | View details for HC Wainwright rating of NovoCure (NASDAQ:NVCR) on 12/2/2024 |
XOMA XOMA | $27.13 +8.0% | 12/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $117.00 -> $123.00 | N/A | View details for HC Wainwright rating of XOMA (NASDAQ:XOMA) on 12/2/2024 |
CYTK Cytokinetics | $48.87 +4.6% | 12/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $120.00 -> $120.00 | N/A | View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 12/2/2024 |
EXK Endeavour Silver | $3.71 +1.6% | 12/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.25 -> $7.25 | N/A | View details for HC Wainwright rating of Endeavour Silver (NYSE:EXK) on 12/2/2024 |
DGHI Digihost Technology | $1.77 -1.7% | 12/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.50 -> $2.50 | N/A | View details for HC Wainwright rating of Digihost Technology (NASDAQ:DGHI) on 12/2/2024 |
SLNO Soleno Therapeutics | $45.18 0.0% | 12/2/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $70.00 -> $70.00 | N/A | View details for HC Wainwright rating of Soleno Therapeutics (NASDAQ:SLNO) on 12/2/2024 |
KZR Kezar Life Sciences | $6.38 -2.1% | 12/2/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Neutral -> Neutral | | N/A | View details for HC Wainwright rating of Kezar Life Sciences (NASDAQ:KZR) on 12/2/2024 |
SPRO Spero Therapeutics | $0.96 -4.3% | 12/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 -> $5.00 | N/A | View details for HC Wainwright rating of Spero Therapeutics (NASDAQ:SPRO) on 12/2/2024 |
MRUS Merus | $41.85 -0.6% | 12/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $85.00 -> $85.00 | N/A | View details for HC Wainwright rating of Merus (NASDAQ:MRUS) on 12/2/2024 |
LEXX Lexaria Bioscience | $2.23 +0.9% | 12/2/2024 | Reiterated by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Lexaria Bioscience (NASDAQ:LEXX) on 12/2/2024 |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days.
It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year.
This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now |
CLGN CollPlant Biotechnologies | $3.41 -7.1% | 11/29/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $11.00 | N/A | View details for HC Wainwright rating of CollPlant Biotechnologies (NASDAQ:CLGN) on 11/29/2024 |
ALEC Alector | $1.86 +4.5% | 11/29/2024 | Target Lowered by | HC Wainwright | - | Buy | $35.00 -> $7.00 | N/A | View details for HC Wainwright rating of Alector (NASDAQ:ALEC) on 11/29/2024 |
AGEN Agenus | $2.83 +2.5% | 11/29/2024 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Neutral -> Neutral | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 11/29/2024 |
OTLK Outlook Therapeutics | $1.44 +3.6% | 11/29/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for HC Wainwright rating of Outlook Therapeutics (NASDAQ:OTLK) on 11/29/2024 |
ICCM IceCure Medical | $1.12 -2.6% | 11/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.50 -> $2.50 | N/A | View details for HC Wainwright rating of IceCure Medical (NASDAQ:ICCM) on 11/27/2024 |
ESPR Esperion Therapeutics | $2.19 +0.9% | 11/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 -> $16.00 | N/A | View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 11/27/2024 |
FEMY Femasys | $1.09 -0.9% | 11/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 11/27/2024 |
MDWD MediWound | $16.49 -4.1% | 11/27/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $28.00 -> $25.00 | N/A | View details for HC Wainwright rating of MediWound (NASDAQ:MDWD) on 11/27/2024 |
SANA Sana Biotechnology | $1.65 +3.1% | 11/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 -> $8.00 | N/A | View details for HC Wainwright rating of Sana Biotechnology (NASDAQ:SANA) on 11/27/2024 |
CGTX Cognition Therapeutics | $0.63 -0.6% | 11/27/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $5.00 -> $5.00 | N/A | View details for HC Wainwright rating of Cognition Therapeutics (NASDAQ:CGTX) on 11/27/2024 |
AVXL Anavex Life Sciences | $8.63 +1.9% | 11/27/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $40.00 -> $40.00 | N/A | View details for HC Wainwright rating of Anavex Life Sciences (NASDAQ:AVXL) on 11/27/2024 |
NNE Nano Nuclear Energy | $25.19 +3.2% | 11/27/2024 | Reiterated by | HC Wainwright | Analyst S. Joshi | Buy -> Buy | $50.00 -> $50.00 | N/A | View details for HC Wainwright rating of Nano Nuclear Energy (NASDAQ:NNE) on 11/27/2024 |
IREN Iris Energy | $11.81 +3.5% | 11/27/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $13.00 -> $16.00 | N/A | View details for HC Wainwright rating of Iris Energy (NASDAQ:IREN) on 11/27/2024 |
ELBM Electra Battery Materials | $0.38 -2.0% | 11/27/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $1.40 -> $1.30 | N/A | View details for HC Wainwright rating of Electra Battery Materials (NASDAQ:ELBM) on 11/27/2024 |
VKTX Viking Therapeutics | $42.25 +1.8% | 11/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $102.00 -> $102.00 | N/A | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 11/26/2024 |
PSTX Poseida Therapeutics | $9.45 +0.4% | 11/26/2024 | Reiterated by | HC Wainwright | Analyst A. He | Buy -> Neutral | $20.00 -> $9.00 | N/A | View details for HC Wainwright rating of Poseida Therapeutics (NASDAQ:PSTX) on 11/26/2024 |
BHVN Biohaven | $36.26 +2.6% | 11/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $59.00 -> $59.00 | N/A | View details for HC Wainwright rating of Biohaven (NYSE:BHVN) on 11/26/2024 |
SRRK Scholar Rock | $44.78 +6.4% | 11/26/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $40.00 -> $50.00 | N/A | View details for HC Wainwright rating of Scholar Rock (NASDAQ:SRRK) on 11/26/2024 |
INAB IN8bio | $0.25 +3.5% | 11/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | N/A | View details for HC Wainwright rating of IN8bio (NASDAQ:INAB) on 11/26/2024 |
ETON Eton Pharmaceuticals | $12.57 +2.4% | 11/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 -> $15.00 | N/A | View details for HC Wainwright rating of Eton Pharmaceuticals (NASDAQ:ETON) on 11/26/2024 |
RDW Redwire | $13.89 +9.4% | 11/26/2024 | Initiated by | HC Wainwright | Analyst S. Buck | Buy | $18.00 | N/A | View details for HC Wainwright rating of Redwire (NYSE:RDW) on 11/26/2024 |
SAVA Cassava Sciences | $2.35 +2.6% | 11/26/2024 | Downgraded by | HC Wainwright | Analyst V. Bernardino | Buy -> Neutral | $116.00 | N/A | View details for HC Wainwright rating of Cassava Sciences (NASDAQ:SAVA) on 11/26/2024 |
TNYA Tenaya Therapeutics | $1.67 +18.4% | 11/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 -> $18.00 | N/A | View details for HC Wainwright rating of Tenaya Therapeutics (NASDAQ:TNYA) on 11/25/2024 |
BLRX BioLineRx | $0.20 +0.5% | 11/25/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $21.00 -> $9.00 | N/A | View details for HC Wainwright rating of BioLineRx (NASDAQ:BLRX) on 11/25/2024 |
PTN Palatin Technologies | $0.97 +12.5% | 11/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.00 -> $17.00 | N/A | View details for HC Wainwright rating of Palatin Technologies (NYSEAMERICAN:PTN) on 11/25/2024 |
RMTI Rockwell Medical | $2.08 +1.5% | 11/25/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $9.00 -> $7.00 | N/A | View details for HC Wainwright rating of Rockwell Medical (NASDAQ:RMTI) on 11/25/2024 |
NRXP NRx Pharmaceuticals | $1.50 -1.3% | 11/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $19.00 -> $19.00 | N/A | View details for HC Wainwright rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 11/25/2024 |
LGVN Longeveron | $1.65 +3.1% | 11/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Longeveron (NASDAQ:LGVN) on 11/25/2024 |
RAPT RAPT Therapeutics | $0.83 +2.2% | 11/25/2024 | Reiterated by | HC Wainwright | - | Neutral | | N/A | View details for HC Wainwright rating of RAPT Therapeutics (NASDAQ:RAPT) on 11/25/2024 |
AXSM Axsome Therapeutics | $90.73 +1.1% | 11/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $180.00 -> $180.00 | N/A | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 11/25/2024 |
LEXX Lexaria Bioscience | $2.23 +0.9% | 11/25/2024 | Reiterated by | HC Wainwright | Analyst Y. Chen | Buy -> Buy | $10.00 -> $10.00 | N/A | View details for HC Wainwright rating of Lexaria Bioscience (NASDAQ:LEXX) on 11/25/2024 |
ORKA Oruka Therapeutics | $20.31 -2.2% | 11/25/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $45.00 -> $45.00 | N/A | View details for HC Wainwright rating of Oruka Therapeutics (NASDAQ:ORKA) on 11/25/2024 |
NGNE Neurogene | $22.64 +2.5% | 11/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $55.00 -> $55.00 | N/A | View details for HC Wainwright rating of Neurogene (NASDAQ:NGNE) on 11/25/2024 |
RYTM Rhythm Pharmaceuticals | $56.12 +1.2% | 11/25/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $69.00 -> $69.00 | N/A | View details for HC Wainwright rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 11/25/2024 |
CARM Carisma Therapeutics | $0.42 -5.3% | 11/25/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $8.00 -> $5.00 | N/A | View details for HC Wainwright rating of Carisma Therapeutics (NASDAQ:CARM) on 11/25/2024 |
ABEO Abeona Therapeutics | $5.70 +1.2% | 11/25/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for HC Wainwright rating of Abeona Therapeutics (NASDAQ:ABEO) on 11/25/2024 |
GANX Gain Therapeutics | $1.56 -0.6% | 11/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 -> $8.00 | N/A | View details for HC Wainwright rating of Gain Therapeutics (NASDAQ:GANX) on 11/25/2024 |
BBIO BridgeBio Pharma | $26.49 +1.1% | 11/25/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $43.00 -> $49.00 | N/A | View details for HC Wainwright rating of BridgeBio Pharma (NASDAQ:BBIO) on 11/25/2024 |
ASRT Assertio | $0.89 +5.1% | 11/25/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $4.00 -> $4.00 | N/A | View details for HC Wainwright rating of Assertio (NASDAQ:ASRT) on 11/25/2024 |
SRPT Sarepta Therapeutics | $118.97 -0.4% | 11/25/2024 | Initiated by | HC Wainwright | Analyst M. Kapoor | Sell | $80.00 | N/A | View details for HC Wainwright rating of Sarepta Therapeutics (NASDAQ:SRPT) on 11/25/2024 |
IMUX Immunic | $1.00 -3.8% | 11/25/2024 | Initiated by | HC Wainwright | Analyst M. Caufield | Buy | $10.00 | N/A | View details for HC Wainwright rating of Immunic (NASDAQ:IMUX) on 11/25/2024 |
MYNZ Mainz Biomed | $6.68 +40.0% | 11/25/2024 | Downgraded by | HC Wainwright | Analyst Y. Chen | Buy -> Neutral | | N/A | View details for HC Wainwright rating of Mainz Biomed (NASDAQ:MYNZ) on 11/25/2024 |
JAZZ Jazz Pharmaceuticals | $122.97 +0.1% | 11/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $200.00 -> $200.00 | N/A | View details for HC Wainwright rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 11/22/2024 |
DRTS Alpha Tau Medical | $3.10 -1.0% | 11/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for HC Wainwright rating of Alpha Tau Medical (NASDAQ:DRTS) on 11/22/2024 |
ZYME Zymeworks | $14.14 +4.1% | 11/22/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | $12.00 -> $12.00 | N/A | View details for HC Wainwright rating of Zymeworks (NYSE:ZYME) on 11/22/2024 |
REPL Replimune Group | $12.49 +4.0% | 11/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.00 -> $17.00 | N/A | View details for HC Wainwright rating of Replimune Group (NASDAQ:REPL) on 11/22/2024 |
KRRO Korro Bio | $43.67 +1.3% | 11/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $115.00 -> $115.00 | N/A | View details for HC Wainwright rating of Korro Bio (NASDAQ:KRRO) on 11/22/2024 |
RLYB Rallybio | $0.95 -2.7% | 11/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 -> $5.00 | N/A | View details for HC Wainwright rating of Rallybio (NASDAQ:RLYB) on 11/22/2024 |
NVCR NovoCure | $30.80 +1.3% | 11/21/2024 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Buy -> Buy | $30.00 -> $30.00 | N/A | View details for HC Wainwright rating of NovoCure (NASDAQ:NVCR) on 11/21/2024 |
ARBK Argo Blockchain | $0.63 +3.8% | 11/21/2024 | Reiterated by | HC Wainwright | - | Neutral | | N/A | View details for HC Wainwright rating of Argo Blockchain (NASDAQ:ARBK) on 11/21/2024 |
CAN Canaan | $2.32 +0.4% | 11/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 -> $3.00 | N/A | View details for HC Wainwright rating of Canaan (NASDAQ:CAN) on 11/21/2024 |
BMEA Biomea Fusion | $4.23 +3.7% | 11/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $40.00 -> $40.00 | N/A | View details for HC Wainwright rating of Biomea Fusion (NASDAQ:BMEA) on 11/21/2024 |
QSI Quantum-Si | $1.30 +0.8% | 11/21/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $4.00 -> $5.50 | N/A | View details for HC Wainwright rating of Quantum-Si (NASDAQ:QSI) on 11/21/2024 |
LSTA Lisata Therapeutics | $2.71 +7.5% | 11/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 -> $15.00 | N/A | View details for HC Wainwright rating of Lisata Therapeutics (NASDAQ:LSTA) on 11/21/2024 |
PYXS Pyxis Oncology | $1.69 +9.7% | 11/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Pyxis Oncology (NASDAQ:PYXS) on 11/21/2024 |
RGNX REGENXBIO | $7.62 +2.8% | 11/21/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $40.00 -> $36.00 | N/A | View details for HC Wainwright rating of REGENXBIO (NASDAQ:RGNX) on 11/21/2024 |
MGX Metagenomi | $4.05 +4.9% | 11/21/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 -> $7.00 | N/A | View details for HC Wainwright rating of Metagenomi (NASDAQ:MGX) on 11/21/2024 |
KURA Kura Oncology | $9.01 +0.4% | 11/21/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $32.00 -> $37.00 | N/A | View details for HC Wainwright rating of Kura Oncology (NASDAQ:KURA) on 11/21/2024 |
SAGE Sage Therapeutics | $5.61 +12.2% | 11/20/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | $14.00 -> $14.00 | N/A | View details for HC Wainwright rating of Sage Therapeutics (NASDAQ:SAGE) on 11/20/2024 |
ARGX argenx | $623.82 -0.4% | 11/20/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $617.00 -> $617.00 | N/A | View details for HC Wainwright rating of argenx (NASDAQ:ARGX) on 11/20/2024 |